Gonadorelin

FDA Approved

Gonadorelin (GnRH)

Category
Sexual Health
Aliases
GnRH, LHRH, Factrel
Administration
Subcutaneous injection, Intravenous (diagnostic use)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Because it acts through a single, fast hormone pulse rather than a sustained buildup, most users don't describe a distinct day-to-day sensation this early in a fertility-support protocol.

  2. 2

    3–4 Weeks

    Continued pulsatile dosing is generally required before meaningful hormonal changes are expected.

  3. 3

    5–7 Weeks

    Fertility-focused users at this stage often begin monitoring relevant lab markers alongside any felt changes.

  4. 4

    8–10 Weeks

    Effects, where present, tend to be gradual rather than sudden, tracked through lab work rather than day-to-day sensation.

  5. 5

    11–15 Weeks

    Long-term users typically evaluate outcomes through fertility-related lab markers monitored by a physician.

  6. 6

    16–20 Weeks

    Available evidence does not describe a distinct felt sensation at this duration; monitoring remains lab-based.

  7. 7

    21–24 Weeks

    By this stage, most users are evaluating outcomes in consultation with a physician rather than relying on felt sensation alone.

⚠️ Research context only. This is not medical advice and results are not guaranteed.